List of insiders holdings for ANGIODYNAMICS INC:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| EZ EM INC 10% Owner | 2004-10-12 13:17:07 | 9,200,000 0 | 9,200,000 | Form 4 |
| STERN HOWARD S Director 10% Owner | 2005-12-29 10:00:06 | 1,749,584 0 | 1,749,584 | Form 4 |
| Estate of Howard S. Stern 10% Owner | 2007-06-28 15:08:41 | 1,324,685 0 | 1,324,685 | Form 13D |
| Clemmer James C President and CEO | 2024-10-08 16:32:02 | 681,582 0 | 681,582 | Form 4 |
| Stern Linda B 10% Owner | 2008-12-23 16:03:09 | 675,812 0 | 675,812 | Form 13D |
| HOBBS EAMONN P President & CEO | 2009-02-17 17:50:01 | 451,651 0 | 451,651 | Form 4 |
| Burgstahler David F Director 10% Owner | 2017-04-14 16:48:37 | 23,988 381,406 | 405,394 | Form 4 |
| MEYERS DAVID P Director | 2006-08-17 09:12:40 | 390,187 0 | 390,187 | Form 4 |
| DEVIVO JOSEPH President and CEO | 2015-09-11 20:36:57 | 198,451 0 | 198,451 | Form 4 |
| Trowbridge Stephen A EVP and CFO | 2024-10-08 18:27:36 | 172,711 0 | 172,711 | Form 4 |
| ECHENBERG PAUL S Director Emeritus | 2012-04-27 19:15:50 | 154,412 0 | 154,412 | Form 4 |
| DONNELLY HOWARD W Director | 2024-07-19 17:18:30 | 149,376 0 | 149,376 | Form 4 |
| BUCCI VINCENT Director | 2013-10-25 10:54:51 | 88,312 55,000 | 143,312 | Form 4 |
| Meteny Dennis S Director | 2023-07-21 21:11:16 | 140,019 0 | 140,019 | Form 4 |
| GRAHAM PETER J Director | 2006-10-27 10:02:48 | 62,882 66,227 | 129,109 | Form 4 |
| JOHNSON WESLEY Director | 2024-07-19 17:18:32 | 125,863 0 | 125,863 | Form 4 |
| Keltjens Jan President & CEO | 2011-01-21 12:29:25 | 109,276 0 | 109,276 | Form 4 |
| REED JAN STERN Director | 2024-07-19 17:18:33 | 87,359 0 | 87,359 | Form 4 |
| Auen Eileen O'Shea Director | 2024-07-19 17:18:24 | 87,043 0 | 87,043 | Form 4 |
| GOLD JEFFREY Director | 2019-07-19 21:20:00 | 83,640 0 | 83,640 | Form 4 |
| Gould Kevin J Director | 2020-07-16 19:06:28 | 77,504 0 | 77,504 | Form 4 |
| Licitra Karen A Director | 2024-07-19 17:18:25 | 72,760 0 | 72,760 | Form 4 |
| ROSSELL ROBERT M VP - Marketing | 2009-10-13 17:42:47 | 67,995 0 | 67,995 | Form 4 |
| Campbell Chad Thomas SVP/GM, Vascular Access | 2024-08-02 21:48:43 | 67,808 0 | 67,808 | Form 4 |
| Tarnoff Michael E Director | 2024-07-19 17:18:32 | 65,703 0 | 65,703 | Form 4 |
| Mitchell Robert D Executive VP and COO | 2007-08-20 19:37:54 | 63,542 0 | 63,542 | Form 4 |
| Centea Scott SVP/GM, VIT | 2023-09-21 21:17:23 | 62,951 0 | 62,951 | Form 4/A |
| FLAHERTY ROBERT E Director | 2008-08-08 16:41:29 | 50,200 0 | 50,200 | Form 4 |
| Wallace Lynda M. SVP - Business Development | 2010-05-19 14:52:35 | 50,000 0 | 50,000 | Form 4 |
| LaPorte Steve Director | 2018-07-20 21:27:34 | 48,484 0 | 48,484 | Form 4 |
| GERSUK D JOSEPH EVP - CFO | 2012-09-11 18:57:29 | 47,275 0 | 47,275 | Form 4 |
| Nighan Warren JR SVP Quality and Regulatory | 2024-10-10 15:22:57 | 45,877 0 | 45,877 | Form 4 |
| RECINELLA DANIEL VP - Product Development | 2007-08-20 19:33:37 | 41,174 0 | 41,174 | Form 4 |
| McDonald David SVP - Business Development | 2009-02-04 14:33:56 | 40,800 0 | 40,800 | Form 3 |
| Morris Sean SVP - General Manager | 2009-02-11 16:02:39 | 40,253 0 | 40,253 | Form 3 |
| Piccinini Laura SVP International | 2024-08-02 21:55:48 | 40,006 0 | 40,006 | Form 4 |
| Frost Mark T EVP and CFO | 2015-08-07 16:44:03 | 38,389 0 | 38,389 | Form 4 |
| Burgess Lorinda Director | 2024-07-19 17:18:29 | 37,582 0 | 37,582 | Form 4 |
| Casciaro Gregory D Director | 2006-08-17 09:11:01 | 37,500 0 | 37,500 | Form 4 |
| PANZER ALAN SVP, GM - Vascular | 2012-08-21 18:33:22 | 37,500 0 | 37,500 | Form 4 |
| KUNST BRIAN VP - Regulatory Affairs | 2007-08-20 19:29:59 | 36,780 0 | 36,780 | Form 4 |
| Helsel Dave SVP Global Operations and R&D | 2023-09-21 21:23:57 | 34,462 0 | 34,462 | Form 4/A |
| GERARDI JOSEPH G Vice President | 2007-08-20 19:26:11 | 32,992 0 | 32,992 | Form 4 |
| Kapusta Matthew C SVP, Business Development | 2014-11-19 16:08:25 | 30,062 0 | 30,062 | Form 4 |
| Simpson Robert Arthur SVP/GM, Global Vascular | 2019-08-19 22:00:02 | 25,883 0 | 25,883 | Form 4 |
| Bourne George W. IV CTO and COO | 2014-08-08 21:45:40 | 23,613 0 | 23,613 | Form 4 |
| APPLING WILLIAM M Vice-President - Research | 2010-09-07 17:56:32 | 23,386 0 | 23,386 | Form 4 |
| SOTO JOHN SVP and CCO | 2015-09-11 20:39:03 | 22,452 0 | 22,452 | Form 4 |
| Etlinger Richard Scott SVP - Global Operations | 2012-08-21 18:29:03 | 21,957 0 | 21,957 | Form 4 |
| Greiner Charles R VP - Global Franchise | 2016-05-09 16:05:37 | 20,910 0 | 20,910 | Form 4 |
| Richard Stark SVP, GM - Oncology | 2017-11-17 16:08:36 | 20,754 0 | 20,754 | Form 4 |
| McGill Stephen SVP, GM - International | 2014-01-30 14:01:35 | 20,715 0 | 20,715 | Form 4 |
| Solano Scott J. Interim CEO | 2011-08-05 20:12:46 | 19,445 0 | 19,445 | Form 4 |
| MAPES HAROLD VP - Operations | 2010-09-07 17:43:47 | 18,684 0 | 18,684 | Form 4 |
| ROSENZWEIG RICHARD C SVP and General Counsel | 2023-02-07 16:00:52 | 15,730 0 | 15,730 | Form 4 |
| Boucher Brent J. SVP and GM of Oncology | 2020-02-18 19:03:16 | 15,416 0 | 15,416 | Form 4 |
| Greiner Michael EVP and CFO | 2019-10-18 18:33:20 | 15,320 0 | 15,320 | Form 4 |
| Orsatti Charles Thomas Director | 2011-08-05 20:13:17 | 14,000 0 | 14,000 | Form 4 |
| McCarthy Shawn P SVP - General Manager | 2010-08-30 17:27:09 | 10,392 0 | 10,392 | Form 4/A |
| Shea Paul J VP - Sales | 2007-08-10 15:36:39 | 5,112 0 | 5,112 | Form 4 |
| Avista Capital Partners GP LLC Avista Capital Partners L.P. Avista Capital Partners (Offshore) L.P. Navilyst Medical Co-Invest LLC 10% Owner | 2017-04-28 17:26:56 | 0 0 | 0 | Form 13D |
| Venkataraman Sriram Director | 2016-08-05 16:39:03 | 0 0 | 0 | Form 4 |